Increased expression of DEF6 has been shown to be correlated with the malignant behavior of extra-skeletal myxoid chondrosarcoma [18], colorectal cancer [19], breast cancer cells [20], and oral squamous cell carcinoma [21]. This evidence concerns the gene DEF6 and breast cancer.